Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Measure the 1 year survival of non small cell lung cancer (NSCLC) patients who are being
treated with pemetrexed in combination with cisplatin and radiation.